AMPLIFIER THERAPEUTICS
Live / Registered — Registered (as of 27 Jan 2026)
What this means for you
Registered since 27 Jan 2026. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97739348
- Registration number
- 8118892
- Mark type
- Stylized text
- Filed
- 03 Jan 2023
- Published for opposition
- 07 May 2024
- Registered
- 27 Jan 2026
- Attorney of record
- Matthew D. Delaney
Goods and services
- Class 042 — Scientific and technological services: research and development in the field of pharmacologic compounds affecting the cardiovascular system, pharmacologic compounds that produce the benefits of exercise, small molecules, and pharmacologic compounds affecting metabolic system; scientific research for medical purposes in the field of pharmacologic compounds affecting the cardiovascular system, pharmacologic compounds that produce the benefits of exercise, small molecules, and pharmacologic compounds affecting metabolic system
Owner
- AMPLIFIER TX AB, UMEA, SE
- AMPLIFIER TX AB, UMEA, SE
- AMPLIFIER TX AB, UMEA, SE
- Cambrian BioPharma, Inc., New York, NY, US
Prosecution history
- 27 Jan 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 27 Jan 2026 — REGISTERED-PRINCIPAL REGISTER
- 06 Jan 2026 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 06 Jan 2026 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 05 Jan 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 05 Jan 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 17 Dec 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 19 Sept 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 19 Sept 2025 — NON-FINAL ACTION E-MAILED
- 19 Sept 2025 — SU - NON-FINAL ACTION - WRITTEN
- 18 Sept 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 18 Sept 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 18 Sept 2025 — ASSIGNED TO LIE
- 15 Sept 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 11 Jun 2025 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED